Literature DB >> 19475537

Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche.

L Díaz-Flores1, R Gutiérrez, J F Madrid, H Varela, F Valladares, E Acosta, P Martín-Vasallo, L Díaz-Flores1.   

Abstract

We review the morphofunctional characteristics of pericytes and report our observations. After a brief historical background, we consider the following aspects of pericytes: A) Origin in embryonic vasculogenesis (mesenchymal stem cells, neurocrest and other possible sources) and in embryonic and postnatal life angiogenesis (pre-existing pericytes, fibroblast/ myofibroblasts and circulating progenitor cells). B) Location in pericytic microvasculature and in the other blood vessels (including transitional cell forms and absence in lymphatic vessels), incidence (differences depending on species, topographical location, and type and stage of vessels) and distribution (specific polarities) in blood vessels. C) Morphology (cell body, and longitudinal and circumferential cytoplasmic processes), structure (nucleus, cytoplasmic organelles and distribution of microtubules, intermediate filaments and microfilaments) and surface (caveolae system). D) Basement membrane disposition, formation, components and functions. E) Contacts with endothelial cells (ECs) (peg and socket arrangements, adherent junctions and gap junctions) and with basal membrane (adhesion plaques). F) Molecular expression (pericyte marker identification). G) Functions, such as vessel stabilization, regulation of vascular tone and maintenance of local and tissue homeostasis (contractile capacity and vessel permeability regulation), matrix protein synthesis, macrophage-like properties, immunological defense, intervention in coagulation, participation in mechanisms that regulate the quiescent and angiogenic stages of blood vessels (including the behaviour of pericytes during sprouting angiogenesis and intussuceptive vascular growth, as well as pericyte interactions with endothelium and other cells, and with extracellular matrix) and plasticity, as progenitor cells with great mesenchymal potential, originating other pericytes, fibroblast/myofibroblasts, preadipocytes, chondroblasts, osteoblasts, odontoblasts, vascular smooth muscle and myointimal cells. This mesenchymal capacity is seen in a broad section on the perivascular mesenchymal cell niche hypothesis and in the concept of pericyte and EC "marriage and divorce". H) Peculiar pericyte types, such as hepatic stellate cells (Ito cells), bone marrow reticular cells and mesangial cells. I) Involvement in pathological processes, such as repair through granulation tissue, pericyte-derived tumors, tumor angiogenesis and tumoral cell metastasis, diabetic microangiopathy, fibrosis, atherosclerosis and calcific vasculopathy, lymphedema distichiasis, chronic venous insufficiency, pulmonary hypertension, Alzheimer disease and multiple sclerosis. J) Clinical and therapeutic implications (de-stabilization of vessels or formation of a stable vasculature).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19475537     DOI: 10.14670/HH-24.909

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  228 in total

1.  Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane.

Authors:  Lea Scheppke; Eric A Murphy; Alessandro Zarpellon; Jennifer J Hofmann; Alona Merkulova; David J Shields; Sara M Weis; Tatiana V Byzova; Zaverio M Ruggeri; M Luisa Iruela-Arispe; David A Cheresh
Journal:  Blood       Date:  2011-12-01       Impact factor: 22.113

2.  The skeletal muscle satellite cell: still young and fascinating at 50.

Authors:  Zipora Yablonka-Reuveni
Journal:  J Histochem Cytochem       Date:  2011-12       Impact factor: 2.479

Review 3.  Multipotent mesenchymal stromal cells and the innate immune system.

Authors:  Katarina Le Blanc; Dimitrios Mougiakakos
Journal:  Nat Rev Immunol       Date:  2012-04-25       Impact factor: 53.106

4.  Vascular morphogenesis of adipose-derived stem cells is mediated by heterotypic cell-cell interactions.

Authors:  Daphne L Hutton; Elizabeth A Logsdon; Erika M Moore; Feilim Mac Gabhann; Jeffrey M Gimble; Warren L Grayson
Journal:  Tissue Eng Part A       Date:  2012-05-09       Impact factor: 3.845

5.  The regenerative potential of the kidney: what can we learn from developmental biology?

Authors:  Franca Anglani; Federica Mezzabotta; Monica Ceol; Rosalba Cristofaro; Dorella Del Prete; Angela D'Angelo
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

Review 6.  Formation of cardiovascular tubes in invertebrates and vertebrates.

Authors:  Boris Strilić; Tomás Kucera; Eckhard Lammert
Journal:  Cell Mol Life Sci       Date:  2010-05-20       Impact factor: 9.261

7.  A contemporary atlas of the mouse diaphragm: myogenicity, vascularity, and the Pax3 connection.

Authors:  Pascal Stuelsatz; Paul Keire; Ricardo Almuly; Zipora Yablonka-Reuveni
Journal:  J Histochem Cytochem       Date:  2012-06-21       Impact factor: 2.479

8.  Paracrine signals from mesenchymal cell populations govern the expansion and differentiation of human hepatic stem cells to adult liver fates.

Authors:  Yunfang Wang; Hsin-Lei Yao; Cai-Bin Cui; Eliane Wauthier; Claire Barbier; Martin J Costello; Nicholas Moss; Mitsuo Yamauchi; Marnisa Sricholpech; David Gerber; Elizabeth G Loboa; Lola M Reid
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

9.  Blocking SDF-1α/CXCR4 downregulates PDGF-B and inhibits bone marrow-derived pericyte differentiation and tumor vascular expansion in Ewing tumors.

Authors:  Randala Hamdan; Zhichao Zhou; Eugenie S Kleinerman
Journal:  Mol Cancer Ther       Date:  2013-11-26       Impact factor: 6.261

Review 10.  Brain mesenchymal stem cells: The other stem cells of the brain?

Authors:  Florence Appaix; Marie-France Nissou; Boudewijn van der Sanden; Matthieu Dreyfus; François Berger; Jean-Paul Issartel; Didier Wion
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.